AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 68 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $92,351 | +64481.1% | 318,451 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $143 | -99.9% | 318,451 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $168,000 | -48.3% | 318,451 | -50.5% | 0.00% | 0.0% |
| Q2 2022 | $325,000 | -73.0% | 642,835 | +22.9% | 0.00% | -66.7% |
| Q1 2022 | $1,203,000 | -39.2% | 523,142 | +25.7% | 0.00% | -50.0% |
| Q4 2021 | $1,977,000 | -6.9% | 416,174 | +55.8% | 0.01% | -14.3% |
| Q3 2021 | $2,123,000 | +8.2% | 267,066 | -5.3% | 0.01% | 0.0% |
| Q2 2021 | $1,963,000 | +67.8% | 282,068 | +90.9% | 0.01% | +40.0% |
| Q1 2021 | $1,170,000 | -7.6% | 147,790 | -8.1% | 0.01% | -16.7% |
| Q4 2020 | $1,266,000 | +47.2% | 160,885 | +32.6% | 0.01% | +20.0% |
| Q3 2020 | $860,000 | -72.1% | 121,344 | -63.5% | 0.01% | -75.0% |
| Q2 2020 | $3,078,000 | +3040.8% | 332,731 | +2498.9% | 0.02% | +1900.0% |
| Q3 2019 | $98,000 | -93.1% | 12,803 | -93.8% | 0.00% | -90.9% |
| Q2 2019 | $1,423,000 | +88.0% | 207,794 | +121.0% | 0.01% | +57.1% |
| Q1 2019 | $757,000 | – | 94,027 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |